FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/04/024436 [Registered on: 01/04/2020] Trial Registered Prospectively
Last Modified On: 22/03/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Preventive 
Study Design  Single Arm Study 
Public Title of Study   Management of Ashrigdhar by a traditional yog (chopchini, muchukunda, marich and sunthi ) 
Scientific Title of Study   A Pharmaco-clinical evaluation of Madhusnuhi(Smilax Ovalifolia Roxb.) with special reference of ashrigdara 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  priyanka galav 
Designation  MD scholar 
Affiliation  Institue of post graduate teaching and research in Ayurved jamnagar in  
Address  Room no-316 P.G.Girls Hostel Ayurvedic college IPGT and RA jamnagar, Gujarat

Jamnagar
GUJARAT
361008
India 
Phone  9783683890  
Fax    
Email  priyanka.galav92@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof RN Acharya  
Designation  prof. and head of Dravyaguna 
Affiliation  Institute of post graduate teaching and research in Ayurved, jamnagar GUJARAT 
Address  Prof and HOD of Dravyaguna department, Room no-329 institutional building IPGTRA jamnagar, gujarat

Jamnagar
GUJARAT
361008
India 
Phone  9924585855  
Fax    
Email  drrnacharya@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof RN Acharya  
Designation  Prof and HOD of Dravyaguna department 
Affiliation  Institute of Post graduate teaching and research in Ayurved, jamnagar GUJARAT 
Address  Room no-329 institutional building IPGTRA jamnagar, gujarat

Jamnagar
GUJARAT
361008
India 
Phone  9924585855  
Fax    
Email  drrnacharya@gmail.com  
 
Source of Monetary or Material Support  
Institute of post graduate teaching and research in ayurveda jamnagar 
 
Primary Sponsor  
Name  Institute of post graduate teaching and research in ayurveda jamnagar 
Address  Ayurvedic college , jamnagar Gujarat 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Priyanka Galav  Institute of post graduate teaching and research in Ayurveda  OPD No 10 jamnagar Gujarat
Jamnagar
GUJARAT 
9783683890

priyanka.galav92@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N938||Other specified abnormal uterine and vaginal bleeding,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Madhusnuhi(smilax ovalifolia) 5gm,sunthi(zinziber official)2.5gm,Marich(piper nigram)1.5gm,Muchukunda(pterospermum acerifolium)5gm  Dose- 5 gm once in a day Route- Oral administration. 
Comparator Agent  Not applicable as study is single arm trial.  Not applicable as study is single arm trial. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Female 
Details  1.patients having signs and symptoms of Asridgara(DUB)such as excessive bleeding per vaginum, backaches, pain in lower abdomen and weakness 
 
ExclusionCriteria 
Details  1.age below 18 years
2.chronic cases of >1 years history
3.Bleeding due to erosion, cancer and fibroid
4.Bleeding from the site other than the uterus
5.suffering with systemic disease like Diabetes, Hypertension, Malignsncy, tuberculosis, renal diseases,liver diseases etc. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Relief in signs and symptoms of Asridgara (DUB) such as excessive bleeding per vaginum, Backaches, pain in lower abdomen and weakness etc. and as described in Ayurvedic classics.  7 days  
 
Secondary Outcome  
Outcome  TimePoints 
Haemoglobin befor and after the clinical trial.  2 Month. 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   20/04/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not yet Published. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  
An open labelled clinical study will be carried out to assess the role of Madhusnuhi yoga  on patients of Asrigdara after getting approval of IEC (Ref no: PGT/7/-A/ethics/2019-20/2593) dated 10.01.2020 Clinically diagnosed 20 cases of Asrigdara among the patients visiting the OPD of PTSR department were supplied with 5 gm of Madhusnuhi yoga for oral administration for a duration for 7 days. 
The result will be considered as relief in signs and symptoms of Asridgara (DUB) such as excessive bleeding per vaginum, Backaches, pain in lower abdomen and weakness etc. and as described in Ayurvedic classics.
 
Close